Exane Derivatives’s T-Mobile US TMUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-550
Closed -$70.6K 935
2022
Q1
$70.6K Buy
+550
New +$65.5K 0.02% 518
2021
Q4
Sell
-23,815
Closed -$3.04M 984
2021
Q3
$3.04M Buy
23,815
+1,498
+7% +$209K 0.73% 24
2021
Q2
$3.3M Sell
22,317
-3,394
-13% -$468K 0.75% 24
2021
Q1
$3.22M Sell
25,711
-2,795
-10% -$352K 0.92% 24
2020
Q4
$3.84M Sell
28,506
-2,937
-9% -$363K 1.13% 18
2020
Q3
$3.6M Buy
31,443
+2,210
+8% +$245K 1.04% 23
2020
Q2
$3.04M Buy
29,233
+17,923
+158% +$1.72M 0.81% 32
2020
Q1
$949K Sell
11,310
-10,351
-48% -$876K 0.27% 83
2019
Q4
$1.74M Sell
21,661
-3,430
-14% -$270K 0.32% 87
2019
Q3
$1.98M Buy
25,091
+15,869
+172% +$1.24M 0.35% 71
2019
Q2
$683K Buy
9,222
+9,197
+36,788% +$683K 0.12% 137
2019
Q1
$1.73K Sell
25
-15,047
-100% -$1.05M ﹤0.01% 461
2018
Q4
$958K Sell
15,072
-2,763
-15% -$185K 0.17% 123
2018
Q3
$1.25M Buy
+17,835
New +$1.15M 0.23% 95

Other funds holding TMUS

Exane Derivatives's TMUS Position: Q2 2022 in Review

Exane Derivatives sold out of T-Mobile US (TMUS) in Q2 2022, closing a stake of 550 shares — an estimated $70.6K sold.

Exane Derivatives first reported a position in TMUS in Q3 2018 and held it in 14 quarters. The position peaked at $3.84M in Q4 2020. 1,116 funds tracked by Wall St. Rank hold TMUS as of Q2 2022.

  • Exane Derivatives reported no remaining T-Mobile US position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 550 T-Mobile US shares in Q2 2022, an estimated $70.6K.
  • Exane Derivatives first reported a position in T-Mobile US in Q3 2018 and held it in 14 quarters.
  • Exane Derivatives's T-Mobile US position peaked at $3.84M in Q4 2020.
  • 1,116 funds tracked by Wall St. Rank held T-Mobile US as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.